Platelet-derived formulations exhibit a rich reservoir of bioactive agents and cytokines, including interleukin 1 (IL-1), transforming growth factor beta (TGF-), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), insulin-like growth factor 1 (IGF-1), hepatocyte growth factor (HGF), and basic fibroblast growth factor (-FGF)
Disguised Alpha Research Profile 5-Amino-1MQ is listed for professional research use with an emphasis on documentation, compound identification, research applications, storage awareness, and third-party testing transparency
Trey to discuss your symptoms & goals Full review of our protocol, expectations, pros & cons Deep dive into peptide therapy, hormone therapy, gut health and more
Scaling intranasal delivery to larger species requires adjustments in formulation concentration, droplet size, and administration technique
Protocol: GHRP-6: 100 mcg per injection Mod GRF 1-29: 100 mcg per injection Frequency: 2-3 times daily (same timing, mixed in the same syringe or injected sequentially) Timing: Upon waking (fasted), post-workout, and before bed (fasted) Cycle length: 12-16 weeks The short half-life of Mod GRF 1-29 (without DAC) matches GHRP-6 pulsatile release profile
Price updates and secure checkout access require active account verification
